The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis-Reference-Cited by-同舟云学术

The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis

Published:2016-09 Issue:9 Volume:32 Page:868-871
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Down Carrie¹,Mehta Natasha²,Marks Kristen³

Affiliation:

1. New York Presbyterian Hospital, Weill Cornell, New York, New York.

2. Weill Cornell Medical College, New York, New York.

3. New York Presbyterian Hospital, Weill Cornell, Infectious Disease, New York, New York.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2016.0051

Reference15 articles.

1. Histological Findings and Clinical Characteristics Associated with Hepatic Steatosis in Patients Coinfected with HIV and Hepatitis C Virus

2. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection

3. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies

4. Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data

5. Sonographic fatty liver, overweight and ischemic heart disease

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study;Viruses;2021-07-19

2. Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV–HCV-Coinfected Individuals;International Journal of Environmental Research and Public Health;2020-12-17

3. Riesgo de enfermedad cardiovascular en pacientes con infección VIH en tratamiento antirretroviral;Revista Clínica Española;2020-04

4. Risk of cardiovascular disease in patients with HIV infection undergoing antiretroviral therapy;Revista Clínica Española (English Edition);2020-04

5. Elevated Fatty Liver Index as a Risk Factor for All‐Cause Mortality in Human Immunodeficiency Virus–Hepatitis C Virus–Coinfected Patients (ANRS CO13 HEPAVIH Cohort Study);Hepatology;2020-01-24